Does anyone know how it is determined which TKI goes to each individual? Is it just the onc's personal preference, the most convincing drug rep, or something else. I've been taking Sprycel 100 since day one, but I've read that it's to be used after the others have stopped working. I was dx in accelerated phase, so wonder if that has anything to do with it. I suppose I'm just wondering, if Sprycel is the last resort, will I still be able to use one of the others if and/or when it stops working.